These data from 200 randomly selected ROSE trial study participants provided us by the PETAL research network, complete with serial plasma samples over 48 h and a robust, deidentified clinical outcomes database, make this, to the best of our knowledge, the largest clinical cohort interrogated for the role of cell-free DNA and MPO-DNA complex levels in ARDS patients. Here, MPO is linked to acute respiratory distress syndrome.